Search

everythinglearnresearchcommunity

for

Search:↓

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Wharton’s Jelly stem cells from the umbilical cord improve skin healing and hair growth without scarring.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

Horse skin stem cells combined with platelet-rich plasma improve skin healing.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

PRP helps skin heal, possibly through special cells called telocytes.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

The woman was diagnosed with Vogt–Koyanagi–Harada disease and successfully treated with medication, restoring her vision and stopping headaches.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Hair transplantation can effectively treat stable eyebrow hair loss in alopecia areata patients.

New treatments for male hypogonadism are effective and should be personalized.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.